Pembroke Management’s CareDx CDNA Stock Holding History

Pembroke Management’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-105,191	Closed	-$6.67M	–	74
2021 Q3	$6.67M	Sell	105,191 -63	-0.1%	-$4.8K	0.5%	56
2021 Q2	$9.63M	Sell	105,254 -954	-0.9%	-$75.8K	0.76%	52
2021 Q1	$7.23M	Buy	106,208 +25,955	+32%	+$2.02M	0.6%	53
2020 Q4	$5.81M	Buy	+80,253	New	+$4.65M	0.49%	56

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Pembroke Management's CDNA Position: Q4 2021 in Review

Pembroke Management sold out of CareDx (CDNA) in Q4 2021, closing a stake of 105,191 shares — an estimated $6.67M sold.

Pembroke Management first reported a position in CDNA in Q4 2020 and held it in 4 quarters. The position peaked at $9.63M in Q2 2021. 224 funds tracked by Wall St. Rank hold CDNA as of Q4 2021.

Pembroke Management reported no remaining CareDx position as of Q4 2021 after selling out during the quarter.
Pembroke Management sold 105,191 CareDx shares in Q4 2021, an estimated $6.67M.
Pembroke Management first reported a position in CareDx in Q4 2020 and held it in 4 quarters.
Pembroke Management's CareDx position peaked at $9.63M in Q2 2021.
224 funds tracked by Wall St. Rank held CareDx as of Q4 2021.

Based on Pembroke Management's 13F filing for Q4 2021, filed 9 Feb 2022.